MedPath

青海晶珠藏药高新技术产业股份有限公司

Ownership
-
Established
1998-05-08
Employees
-
Market Cap
-
Website
http://www.jingzhuzangyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

NMPA:32

Drug Approvals

Compound Vitamin U Capsules

Product Name
复方维生素U胶囊
Approval Number
国药准字H20054760
Approval Date
Apr 30, 2021
NMPA

鹿茸口服液

Approval Number
国药准字Z20053899
Approval Date
Apr 30, 2021
NMPA

Chlorophyllin Copper Sodium Capsules

Product Name
叶绿素铜钠胶囊
Approval Number
国药准字H20054758
Approval Date
Apr 30, 2021
NMPA

Inosine Oral Solution

Product Name
肌苷口服液
Approval Number
国药准字H20054756
Approval Date
Apr 30, 2021
NMPA

蛇胆川贝液

Approval Number
国药准字Z20053896
Approval Date
Apr 30, 2021
NMPA

人参口服液

Approval Number
国药准字Z20053900
Approval Date
Apr 30, 2021
NMPA

咳特灵胶囊

Approval Number
国药准字Z20053894
Approval Date
Apr 30, 2021
NMPA

Paracetamol, Caffein,Atificial Cow-bezoa

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H20054761
Approval Date
Apr 30, 2021
NMPA

Compound Bifendate Granules

Product Name
复方联苯双酯颗粒
Approval Number
国药准字H20054757
Approval Date
Apr 30, 2021
NMPA

消栓口服液

Approval Number
国药准字Z20053897
Approval Date
Apr 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.